Influence of dextran-70 on the cytotoxic effect of EMAP II on glioma cells in vitro
Open Access
- 1 September 2023
- journal article
- research article
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Faktori eksperimental'noi evolucii organizmiv
- Vol. 32, 130-135
Abstract
Aim. To evaluate with the use of the MTT test how the formation of a nanocomposite complex of the cytokine EMAP II with dextran-70 affects the cytotoxic effect of the free protein in glioma cell cultures of different origins: a standart culture U251MG cells and a primary culture of cells obtained from tumor fragments. Methods. The recombinant polypeptide EMAP II was obtained using gene engineering biotechnology. The study was conducted on the standard human glioma cell line U251MG and on primary cell cultures obtained from tumor fragments after surgical removal. Cell viability was determined using the MTT test. The cells were cultivated for a day with t the different concentrations from 1.0 pM to 10 μM of EMAP II and the EMAP II + dextran-70 complex im serum-free standard DMEM growth medium. Results. In our previous works, it has been shown that EMAP II exhibited dose-dependent cytotoxic properties in the concentration range of 1.0 pM – 10 μM on U251MG glioma cells and in primary cell cultures. The dose-effect curve in all cases has a complex pattern. Dextran-70 does not fundamentally affect the cytotoxic effect of EMAP II, but depending on the dose and type of cells, it shows the ability to slightly weaken/enhance the effect of the free protein. An increased sensitivity of the primary culture of glioma cells to the cytotoxic effect of the EMAP II + dextran-70 complex was revealed. Conclusions. Dextran-70 does not fundamentally affect the cytotoxic effect of EMAP II, but depending on the dose and type of cells, it shows the ability to slightly weaken/enhance the effect of the latter.Keywords
This publication has 14 references indexed in Scilit:
- Перший досвід використання імунотерапії на основі дендритних клітин в комплексному лікуванні хворих на гліобластому в УкраїніClinical Oncology, 2019
- Tetrazolium salts and formazan products in Cell Biology: Viability assessment, fluorescence imaging, and labeling perspectivesActa Histochemica, 2018
- Prediction of Protein Aggregation in High Concentration Protein Solutions Utilizing Protein-Protein Interactions Determined by Low Volume Static Light ScatteringJournal of Pharmaceutical Sciences, 2016
- Protein aggregation and its impact on product qualityCurrent Opinion in Biotechnology, 2014
- Factors affecting patient's perception of anticancer treatments side-effects: an observational studyExpert Opinion on Drug Safety, 2013
- Development of dextran nanoparticles for stabilizing delicate proteinsDiscover Nano, 2013
- Assessment of the Evolution of Cancer Treatment TherapiesCancers, 2011
- Endothelial Monocyte-Activating Polypeptide II, a Tumor-Derived Cytokine That Plays an Important Role in Inflammation, Apoptosis, and AngiogenesisJournal of Immunotherapy, 2000
- Cytokine activity of the non-catalytic EMAP-2-like domain of mammalian tyrosyl-tRNA synthetaseBiopolymers and Cell, 1999
- Endothelial-monocyte-activating polypeptide IIThe International Journal of Biochemistry & Cell Biology, 1996